Epigenetics
December 2024
Some important atypical antipsychotic drugs target the serotonergic receptor 2A (5-HTR). Currently, new therapeutic strategies are needed to offer faster onset of action with fewer side effects and, therefore, greater efficacy in a substantial proportion of patients with neuropsychological disorders such as Autism and Parkinson. The main objective of this work was to use SBDD methods to identify new hit compounds potentially useful as precursors of novel and selective 5-HTR antagonists.
View Article and Find Full Text PDF